mp.weixin.qq.com·· 8 hours agoPickScore77
FDA approves RYZUMVI, the first non-cholinergic prescription eye drop for presbyopia
In brief
On October 16, 2026, the FDA approved RYZUMVI (phentolamine ophthalmic solution 0.75%) from Viatris and Opus Genetics for presbyopia in adults. It is the first prescription eye drop for the condition that does not rely on the cholinergic pathway.
Why it matters
The article outlines the mechanism, key clinical data and market landscape behind the first non-cholinergic presbyopia drug approval.
Source: mp.weixin.qq.com · mp.weixin.qq.com